| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 | | Total Revenue | 2,175 | 1,581 | 646 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 2,175 | 1,581 | 646 | | | Operating Expenses | | Research Development | 15,269 | 12,695 | 9,291 | | Selling General and Administrative | 5,672 | 5,704 | 4,927 | | Non Recurring | (1,472) | (1,634) | 14 | | Others | 441 | 923 | 860 | | | | Total Operating Expenses | 19,911 | 17,689 | 15,092 | | | | Operating Income or Loss | (17,736) | (16,108) | (14,447) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (300) | 1,419 | (9,218) | | Earnings Before Interest And Taxes | (18,036) | (15,958) | (23,664) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (18,036) | (15,958) | (23,664) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,036) | (14,689) | (23,664) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (18,036) | (14,689) | (23,664) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,036) | ($14,689) | ($23,664) |
|
0.51% Nasdaq 
0.02 (0.56%) 
Income Statement
